Evidence map›Paper›PMID 38727960›Full record

Observational studyJapanese journal of radiology2024

Maximum tumor diameter and renal function can predict the declining surface dose rate after

Takashi Ono, Mayumi Ichikawa, Takeo Tanada, Chika Kanezawa, Hiraku Sato

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Japanese journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Takashi OnoDepartment of Radiation Oncology, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-9585, Japan. abc1123513@gmail.com.ORCID http://orcid.org/0000-0002-9711-1158
Mayumi IchikawaDepartment of Radiation Oncology, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-9585, Japan.
Takeo TanadaDepartment of Radiology, Yamagata University Hospital, 2-2-2, Iida-Nishi, Yamagata, 990-9585, Japan.
Chika KanezawaDepartment of Radiology, Yamagata University Hospital, 2-2-2, Iida-Nishi, Yamagata, 990-9585, Japan.
Hiraku SatoDepartment of Radiology, Yamagata University Hospital, 2-2-2, Iida-Nishi, Yamagata, 990-9585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to develop a user-friendly prediction formula for dose rate adjustment after initial MATERIALS AND

methodsThis study included consenting patients in a prospective observational study who underwent their first treatment in four cycles of

resultsAmong the 13 patients (seven males, six females, median age: 59 years), logarithmically transformed total tumor volume (cc) and maximum tumor diameter (mm) of primary tumors or metastases showed strong correlations (p < 0.001, R

conclusionThe present study showed that the maximum tumor diameter and renal function affected the declining the dose rate of patients surface after

Indexed as

OctreotideOrganometallic CompoundsAdultAgedFemaleHumansJapanKidneyKidney Function TestsMaleMiddle AgedNeuroendocrine TumorsProspective StudiesRadiopharmaceuticalsRadiotherapy DosageTumor Burdenlutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadiopharmaceuticals177Lu-DotatateDose ratePeptide receptor radionuclide therapyRenal functionTumor diameter

Identifiers

PMID38727960
PMCPMC11364653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.